Bordeaux, Boston, April 13, 2016:  IMPLANET (Euronext: IMPL, FR0010458729, PEA-PME eligible; OTCQX: IMPZY), a medical technology company specializing in vertebral and knee-surgery implants, announces that its sponsored Level 1 American Depositary Receipts (ADRs) will commence trading today in the United States on OTCQX® International (“OTCQX”), under the symbol IMPZY, with each ADR representing 2 ordinary […]